2019-12-27 17:49:52

Plans for the partnership for radiation therapy company ViewRay with Medtronic and Elekta are in the works. News of the new joint decision has already increased ViewRay shares up 37% in the after-hours trading. The agreement is however contingent upon ViewRay raising $75 million in equity capital, so the agreement is non-binding at the time. The collaboration is hopeful for ViewRay to work with Elekta and run clinical studies to research MR-guided radiation therapy. The details of the agreement made with Medtronic are less available in this stage, but analysts believe the investments from Medtronic s partnership show strong signs . To read more on this new partnership with these companies read here.

OTHER ARTICLES:

• Understanding Linear Accelerators and Their Role in Cancer Treatment
• Israeli Child Receives Pioneering Seated Proton Therapy with Innovative System
• Significant Milestone Reached in Compact Particle Accelerator Technology
• Innovative Radiotherapy Method Potentially Halves Treatment Duration for Head and Neck Cancer
• WSU Veterinary Hospital Installs a New Linear Accelerator to Fight Cancer
• Patients Privately Pay $2,500 for a Full-Body MRI Scan to Detect Cancer
• MIT and Dana-Farber's Breakthrough in Identifying Cancer Origins
• Available Diagnostic Imaging for Smaller Communities & Young Athletes
• New MR, PET Images Analyze Alzheimer’s Biomarkers
• Prostate Cancer Treatment Vastly Improved